Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SHE:002399)
China flag China · Delayed Price · Currency is CNY
12.21
-0.24 (-1.93%)
Jun 5, 2025, 2:45 PM CST

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
Preparation
2.98B
Log In
Log In
Log In
Log In
Upgrade
Preparation Growth
-7.21%
Log In
Log In
Log In
Log In
Upgrade
API
1.31B
Log In
Log In
Log In
Log In
Upgrade
API Growth
-51.09%
Log In
Log In
Log In
Log In
Upgrade
Contract Development and Manufacturing Operations
966.95M
Log In
Log In
Log In
Log In
Upgrade
Contract Development and Manufacturing Operations Growth
-10.80%
Log In
Log In
Log In
Log In
Upgrade
Other
191.79M
Log In
Log In
Log In
Log In
Upgrade
Other Growth
0.35%
Log In
Log In
Log In
Log In
Upgrade
Trypsin and Other
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
Europe
2.62B
Log In
Log In
Log In
Log In
Upgrade
Europe Growth
-29.87%
Log In
Log In
Log In
Log In
Upgrade
United States
1.28B
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-7.90%
Log In
Log In
Log In
Log In
Upgrade
Other Countries
1.12B
Log In
Log In
Log In
Log In
Upgrade
Other Countries Growth
-13.01%
Log In
Log In
Log In
Log In
Upgrade
China
412.43M
Log In
Log In
Log In
Log In
Upgrade
China Growth
-35.83%
Log In
Log In
Log In
Log In
Upgrade
Hong Kong
18.10M
Log In
Log In
Log In
Log In
Upgrade
Hong Kong Growth
-82.43%
Log In
Log In
Log In
Log In
Upgrade
International
-
Log In
Log In
Log In
Log In
Upgrade
International Growth
-
Log In
Log In
Log In
Log In
Upgrade